Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Immune Response begins trial

IMNR and partner Agouron (La Jolla, Calif.), a subsidiary of Warner-Lambert (WLA), began a Phase III trial of IMNR's

Read the full 197 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE